Selected research
Industry Research
Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Research Report 2026
Market perspective
The global Non-steroidal Anti-inflammatory Drugs (NSAID) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Non-steroidal Anti-inflammatory Drugs (NSAID) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Non-steroidal Anti-inflammatory Drugs (NSAID) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Non-steroidal Anti-inflammatory Drugs (NSAID) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID) include Merck Animal Health, Bayer, Zoetis, St. Joseph, Merial, Generic, Elanco, Ecotrin and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Non-steroidal Anti-inflammatory Drugs (NSAID) market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Company
Merck Animal Health
Bayer
Zoetis
St. Joseph
Merial
Generic
Elanco
Ecotrin
Boehringer Ingelheim
Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Type
Propionic acid derivatives
Sulfonanilides
Anthranilic acid derivatives (Fenamates)
Salicylates
Enolic acid (Oxicam) derivatives
Selective COX-2 inhibitors (Coxibs)
Acetic acid derivatives
Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Application
Human
Animals
Others
Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-steroidal Anti-inflammatory Drugs (NSAID) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Non-steroidal Anti-inflammatory Drugs (NSAID) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-steroidal Anti-inflammatory Drugs (NSAID).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Non-steroidal Anti-inflammatory Drugs (NSAID) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Non-steroidal Anti-inflammatory Drugs (NSAID) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Non-steroidal Anti-inflammatory Drugs (NSAID) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Propionic acid derivatives
- Sulfonanilides
- Anthranilic acid derivatives (Fenamates)
- Salicylates
- Enolic acid (Oxicam) derivatives
- Selective COX-2 inhibitors (Coxibs)
- Acetic acid derivatives
Applications
- Human
- Animals
- Others
Companies covered
- Merck Animal Health
- Bayer
- Zoetis
- St. Joseph
- Merial
- Generic
- Elanco
- Ecotrin
- Boehringer Ingelheim
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size (2021-2032)
- 2.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (2021-2032)
- 2.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Average Price (2021-2032)
- 2.3 Non-steroidal Anti-inflammatory Drugs (NSAID) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Propionic acid derivatives
- 2.3.3 Sulfonanilides
- 2.3.4 Anthranilic acid derivatives (Fenamates)
- 2.3.5 Salicylates
- 2.3.6 Enolic acid (Oxicam) derivatives
- 2.3.7 Selective COX-2 inhibitors (Coxibs)
- 2.3.8 Acetic acid derivatives
- 2.4 Non-steroidal Anti-inflammatory Drugs (NSAID) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Human
- 2.4.3 Animals
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue of Manufacturers (2021-2026)
- 3.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price by Manufacturers (2021-2026)
- 3.5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID), Product Type & Application
- 3.8 Global Manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID), Established Date
- 3.9 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Merck Animal Health
- 4.1.1 Merck Animal Health Company Information
- 4.1.2 Merck Animal Health Business Overview
- 4.1.3 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
- 4.1.5 Merck Animal Health Recent Developments
- 4.2 Bayer
- 4.2.1 Bayer Company Information
- 4.2.2 Bayer Business Overview
- 4.2.3 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
- 4.2.5 Bayer Recent Developments
- 4.3 Zoetis
- 4.3.1 Zoetis Company Information
- 4.3.2 Zoetis Business Overview
- 4.3.3 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
- 4.3.5 Zoetis Recent Developments
- 4.4 St. Joseph
- 4.4.1 St. Joseph Company Information
- 4.4.2 St. Joseph Business Overview
- 4.4.3 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
- 4.4.5 St. Joseph Recent Developments
- 4.5 Merial
- 4.5.1 Merial Company Information
- 4.5.2 Merial Business Overview
- 4.5.3 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
- 4.5.5 Merial Recent Developments
- 4.6 Generic
- 4.6.1 Generic Company Information
- 4.6.2 Generic Business Overview
- 4.6.3 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
- 4.6.5 Generic Recent Developments
- 4.7 Elanco
- 4.7.1 Elanco Company Information
- 4.7.2 Elanco Business Overview
- 4.7.3 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
- 4.7.5 Elanco Recent Developments
- 4.8 Ecotrin
- 4.8.1 Ecotrin Company Information
- 4.8.2 Ecotrin Business Overview
- 4.8.3 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
- 4.8.5 Ecotrin Recent Developments
- 4.9 Boehringer Ingelheim
- 4.9.1 Boehringer Ingelheim Company Information
- 4.9.2 Boehringer Ingelheim Business Overview
- 4.9.3 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
- 4.9.5 Boehringer Ingelheim Recent Developments
5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Scenario by Region
- 5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region: 2021-2032
- 5.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region: 2021-2026
- 5.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region: 2027-2032
- 5.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region: 2021-2032
- 5.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region: 2021-2026
- 5.3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region: 2027-2032
- 5.4 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Country
- 5.4.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2021-2032)
- 5.4.3 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Country
- 5.5.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2021-2032)
- 5.5.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Country
- 5.7.1 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2021-2032)
- 5.7.3 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2021-2032)
- 6.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2021-2032)
- 6.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2021-2032)
- 6.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2021-2032)
- 6.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2021-2032)
- 7.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2021-2032)
- 7.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2021-2032)
- 7.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2021-2032)
- 7.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Value Chain Analysis
- 8.1.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Production Mode & Process
- 8.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors
- 8.2.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Customers
9 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Analyzing Market Dynamics
- 9.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Trends
- 9.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Drivers
- 9.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Opportunities and Challenges
- 9.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst